STEAP1 and prostate carcinoma: Although most of the research related to STEAP1 was conducted in prostate cancer, we believe that STEAP1 could also be an ideal target in other types of malignant tumors as growing evidence has revealed the overexpression of STEAP1 in cancerous cells compared to the normal counterpart.